Carroll K M, Rounsaville B J, Nich C, Gordon L T, Wirtz P W, Gawin F
Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.
Arch Gen Psychiatry. 1994 Dec;51(12):989-97. doi: 10.1001/archpsyc.1994.03950120061010.
Neither the durability of brief ambulatory treatments for cocaine dependence nor the relative ability of psychotherapy vs pharmacotherapy to effect lasting change has been evaluated in well-controlled randomized trials.
We conducted a 1-year naturalistic follow-up of 121 ambulatory cocaine abusers who underwent psychotherapy (cognitive-behavioral relapse prevention or clinical management) and pharmacotherapy (desipramine hydrochloride or placebo) in a 2 x 2 design. Subjects were interviewed 1, 3, 6, or 12 months after the termination of a 12-week course of outpatient treatment. Eighty percent (n = 97) of the subjects who were randomized to treatment were followed up at least once.
First, the effects of study treatments appeared durable over the follow-up; as for the full sample, measures of cocaine use indicated either improvement or no change over posttreatment levels. Second, abstinence during treatment was strongly associated with less cocaine use during follow-up. Third, random effects regression models indicated significant psychotherapy-by-time effects, suggesting a delayed improved response during follow-up for patients who received cognitive-behavioral relapse prevention compared with supportive clinical management.
Our findings suggest a delayed emergence of the effects of cognitive-behavioral relapse prevention, which may reflect the subjects' implementation of the generalizable coping skills conveyed through that treatment. Moreover, these data underline the importance of conducting follow-up studies of substance abusers and other groups because delayed effects may occur after the cessation of short-term treatments.
在严格控制的随机试验中,尚未评估过针对可卡因依赖的简短门诊治疗的持久性,也未评估心理治疗与药物治疗实现持久改变的相对能力。
我们对121名门诊可卡因滥用者进行了为期1年的自然随访,这些患者在一项2×2设计中接受了心理治疗(认知行为复发预防或临床管理)和药物治疗(盐酸地昔帕明或安慰剂)。在为期12周的门诊治疗结束后的1、3、6或12个月对受试者进行访谈。随机接受治疗的受试者中有80%(n = 97)至少接受了一次随访。
首先,研究治疗的效果在随访期间似乎具有持久性;对于整个样本,可卡因使用量的测量结果显示,与治疗后水平相比有所改善或没有变化。其次,治疗期间的戒断与随访期间较少的可卡因使用密切相关。第三,随机效应回归模型显示了显著的心理治疗×时间效应,这表明与支持性临床管理相比,接受认知行为复发预防治疗的患者在随访期间反应改善出现延迟。
我们的研究结果表明,认知行为复发预防治疗效果的出现存在延迟,这可能反映了受试者对通过该治疗所传达的可推广应对技能的实施情况。此外,这些数据强调了对药物滥用者和其他群体进行随访研究的重要性,因为短期治疗停止后可能会出现延迟效应。